{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:40:16Z","timestamp":1780386016676,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.prp.2023.154388","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T19:18:50Z","timestamp":1677266330000},"page":"154388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The protean role of Val804Met RET mutation in thyroid neoplasms: An example of a \u201cMEN2C\u201d syndrome?"],"prefix":"10.1016","volume":"244","author":[{"given":"Cesare","family":"Miani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Giovanni","family":"Locatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Rugiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamile Karina","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Di Loreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Pegolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.prp.2023.154388_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22041726","article-title":"A narrative review of genetic alterations in primary thyroid epithelial cancer","volume":"22","author":"Romei","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.prp.2023.154388_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2023.154388_bib3","unstructured":"Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2019 Aug 15]. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1257\/."},{"issue":"12","key":"10.1016\/j.prp.2023.154388_bib4","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.prp.2023.154388_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrendo.2016.11","article-title":"A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma","volume":"12","author":"Romei","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.prp.2023.154388_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.prp.2023.154388_bib7","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1210\/jc.2017-02529","article-title":"p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer","volume":"103","author":"Loveday","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2023.154388_bib8","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2007-1005","article-title":"RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center","volume":"92","author":"Elisei","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2023.154388_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2023.154388_bib10","first-page":"1059","article-title":"Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2a","volume":"114","author":"Decker","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.prp.2023.154388_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/msy.2000.107103","article-title":"Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG R ATG) mutation","volume":"128","author":"Feldman","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.prp.2023.154388_bib12","first-page":"153","article-title":"Coexistence of MEN 2a and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: Report of a case and e review of the Japanese literature","volume":"25","author":"Oishi","year":"1995","journal-title":"Jpn J. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154388_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/thy.1998.8.781","article-title":"Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2a?","volume":"8","author":"Rone","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2023.154388_bib14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.surg.2009.09.021","volume":"146","author":"Shifrin","year":"2009","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.prp.2023.154388_bib15","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/cancers11101516","article-title":"Elisei R on behalf of the SIE (Italian Society of Endocrinology) Working Group. Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC\/PTC): An Italian Multicenter study","volume":"11","author":"Appetecchia","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154388_bib16","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1245\/s10434-012-2357-8","article-title":"Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity","volume":"19","author":"Wong","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154388_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2478\/enr-2021-0010","article-title":"A case report of simultaneous medullary and papillary carcinoma of thyroid","volume":"55","author":"Ziaolhagh","year":"2021","journal-title":"Endocr. Regul."},{"issue":"2","key":"10.1016\/j.prp.2023.154388_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1677\/erc.1.00901","article-title":"Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature","volume":"12","author":"Rossi","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2023.154388_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1507\/endocrj.52.281","article-title":"Synchronous occurrence of a follicular, papillary and medullary thyroid carcinoma in a recurrent goiter","volume":"52","author":"Cupisti","year":"2005","journal-title":"Endocr. J."},{"issue":"4","key":"10.1016\/j.prp.2023.154388_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13304-012-0152-5","article-title":"Synchronous medullary, papillary and follicular carcinomas in the same thyroid: case report and review of literature","volume":"65","author":"Verdi","year":"2013","journal-title":"Updates Surg."},{"key":"10.1016\/j.prp.2023.154388_bib21","unstructured":"Yao J., Li C., Wang J., et al. Case Report Medullary thyroid carcinoma combined with papillary thyroid carcinoma: case report and literature review. 2020;13(10):2710\u20132717."},{"key":"10.1016\/j.prp.2023.154388_bib22","first-page":"305","article-title":"BRAF and K-RAS mutation in a greek papillary and medullary thyroid carcinoma cohort","volume":"28","author":"Goutas","year":"2008","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.prp.2023.154388_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-010-9117-8","article-title":"Synchronous metastatic medullary and papillary thyroid carcinomas in a patient with germline RET mutation: Case report, molecular analysis, and implications for pathogenesis","volume":"21","author":"Griffith","year":"2010","journal-title":"Endocr. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2023.154388_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40618-016-0526-5","article-title":"Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland","volume":"40","author":"Ciampi","year":"2017","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"10.1016\/j.prp.2023.154388_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2010.01453.x","article-title":"RET codon 804 mutations in multiple endocrine neoplasia 2: genotype-phenotype correlations and implications in clinical management","volume":"79","author":"Mukherjee","year":"2011","journal-title":"Clin. Genet"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:56:32Z","timestamp":1759733792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":25,"alternative-id":["S0344033823000882"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154388","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protean role of Val804Met RET mutation in thyroid neoplasms: An example of a \u201cMEN2C\u201d syndrome?","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154388"}}